---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011589"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2022-06-14T23:59:59+00:00"
generated_at: "2026-06-25T02:06:14.204557+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks shareholders elect eight directors and ratify EY at 2022 annual meeting

## Summary
- Quorum of 81.47% of combined Class A and Class B voting power; 859.9M Class A and 351.5M Class B shares present.
- All eight director nominees elected: Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar, Harry E. Sloan.
- Ratification of Ernst & Young as independent auditor for FY2022 approved with 4,365,263,156 votes for and 5,152,427 against.
- Annual meeting held June 10, 2022; no other proposals or director nominations brought before shareholders.

## SEC filing metadata
- accession: 0000950170-22-011589
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2022-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000095017022011589/0000950170-22-011589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000095017022011589/dna-20220610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011589
- JSON: https://secwatch.observer/filing/0000950170-22-011589.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.